The Indian pharmaceutical and healthcare industries are optimistic about Finance Minister Nirmala Sitharaman’s upcoming Union Budget 2025. Their wish list includes increased healthcare spending, tax cuts for research and development (R&D), and support for infrastructure growth to drive innovation and accessibility. Boosting Research and Development Industry leaders are urging the government to prioritise R&D support, …